Seattle Genetics Reports Third Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. HOOD
10. RGNX

Go back to Seattle Genetics Reports Third Quarter 2015 Financial Results

Seattle Genetics (SGEN) Recorded Record Sales Following Label Expansion; Needham & Company Reiterates Buy

October 30, 2015 1:12 PM EDT

Needham & Company reiterated a Buy rating and $60.00 price target on Seattle Genetics (NASDAQ: SGEN) fallowing the company's 3Q earnings results. Adcetris reported record quarterly sales of $59 million, following the company's label expansion into post transplant Hodgkin's lymphoma (HL).

Analyst Chad Messer commented, "Following... More

Piper Jaffray Upgrades Seattle Genetics (SGEN) to Neutral

October 30, 2015 7:06 AM EDT

Piper Jaffray upgraded Seattle Genetics (NASDAQ: SGEN) from Underweight to Neutral with a price target of $44.00 (from $30.00).

Analyst Edward Tenthoff commented, "GEN reported ADCETRIS sales of $59 million in 3Q:15 and management again raised 2015 ADCETRIS sales guidance to $218-223 million, and our... More

Seattle Genetics (SGEN) Misses Q3 EPS by 1c

October 29, 2015 4:17 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $84.1 million versus the consensus estimate of $82.67 million.

ADCETRIS sales in the third quarter of $59.1 million, an increase from $48.2 million in the third... More